Drug
Budesonide clinical trials
Also written Pulmicort and Entocort.
Counted the way a researcher would: Budesonide with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Budesonide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Budesonide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 14 Feb 1994 · RHINOCORT · NDA 020233 (FDA, Drugs@FDA)
- European Union
- 28 Apr 2014 · DuoResp Spiromax · EMEA/H/C/002348 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
304 studies that test it; most in 2015 (20); 1 more planned to start later
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 3 |
| 2001 | 4 |
| 2002 | 9 |
| 2003 | 8 |
| 2004 | 17 |
| 2005 | 10 |
| 2006 | 12 |
| 2007 | 18 |
| 2008 | 16 |
| 2009 | 13 |
| 2010 | 13 |
| 2011 | 9 |
| 2012 | 9 |
| 2013 | 10 |
| 2014 | 12 |
| 2015 | 20 |
| 2016 | 15 |
| 2017 | 14 |
| 2018 | 10 |
| 2019 | 13 |
| 2020 | 13 |
| 2021 | 13 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 10 |
| 2025 | 6 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 143 · Other 164
AstraZeneca (56) · Dr. Falk Pharma GmbH (16) · Pearl Therapeutics, Inc. (7) · Mayo Clinic (6) · Shire (5) · Bausch Health Americas, Inc. (5) · Allergan (5) · Calliditas Therapeutics AB (4)
Often tested with
Tested in the same studies.
Formoterol (78) · Fluticasone (11) · Glycopyrrolate (10) · Albuterol (8) · Montelukast (6) · Tiotropium (4) · Salmeterol Xinafoate (3) · Dexamethasone (3)
Related medicines
As reviewed, each with the page that says it.
- One of Corticosteroids source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Budesonide is the comparator. A study of two new drugs counts under both.
- 1QMF149 · Novartis Pharmaceuticals · next primary completion Feb 2028
Reaching primary completion within a year · 9, 1 in phase 3
Studies that test Budesonide, phase 3 first.
- Dec 2026Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoEPhase 3 · Dr. Falk Pharma GmbH
- Dec 2026Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell TransplantPhase 2 · University of Utah
- Dec 2026Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative ColitisPhase 4 · Bausch Health Americas, Inc.
- Dec 2026Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer PatientsPhase 2 · Instituto Nacional de Cancerologia de Mexico
- Dec 2026Incidence of Acute Laryngeal Injury Following Endotracheal IntubationPhase 1/2 · Vanderbilt University Medical Center
- Mar 2027Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA NephropathyPhase 4 · Calliditas Therapeutics AB
- May 2027A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationPhase 4 · AstraZeneca
- Jun 202745th Multicenter Airway Research CollaborationPhase 4 · Massachusetts General Hospital
- Jul 2027Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEctionNot applicable · Huashan Hospital
Studies
Open first, then newest update. How each study uses Budesonide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 307
- Little Lungs StudyNot yet recruitingPhase 1/2University of Wisconsin, MadisonNCT06855043Written as Budesonide
- Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial FibrillationRecruitingNot applicableChina National Center for Cardiovascular DiseasesNCT07877519Written as Budesonide
- Ventilation and Perfusion in AsthmaticsRecruitingPhase 4University of MiamiNCT07426458Written as Albuterol-Budesonide
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRecruitingPhase 3AstraZenecaNCT06283966Written as BGF MDI 320/14.4/9.6 μg
- A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationRecruitingPhase 4AstraZenecaNCT07073950Written as Budesonide/Glycopyrronium/Formoterol Fumarate
- Efficacy and Safety of Nefecon on Prevention of Relapse of IgA NephropathyRecruitingPhase 4Nanfang Hospital, Southern Medical UniversityNCT07604311Written as NEFECON
- Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil LevelsRecruitingPhase 4Maria Joyera RodríguezNCT06334575Written as Budesonide
- Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell TransplantRecruitingPhase 2University of UtahNCT05405387Written as Budesonide EC
- Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.Enrolling by invitationEarly Phase 1Mayo ClinicNCT07358234Written as budesonide oral suspension
- Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell TransplantationRecruitingPhase 3Henry Ford Health SystemNCT05509933Written as Budesonide
- 45th Multicenter Airway Research CollaborationRecruitingPhase 4Massachusetts General HospitalNCT07166939Written as Airsupra
- Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal PolypsNot yet recruitingNot applicableSt. Paul's Sinus CentreNCT07528820Written as Budesonide
- Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer PatientsRecruitingPhase 2Instituto Nacional de Cancerologia de MexicoNCT03803787Written as Inhaled budesonide
- Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute SinusitisRecruitingPhase 4Daniel MerensteinNCT06076304Written as Budesonide nasal spray
- Predicting Post Extubation Stridor After Maxillomandibular FixationRecruitingNot applicableMansoura UniversityNCT05839756Written as budesonide
- Anti-Inflammatory Reliever South AfricaRecruitingPhase 3University of KwaZuluNCT06429475Written as Budesonide/formoterol
- Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative ColitisRecruitingPhase 4Bausch Health Americas, Inc.NCT04314375Written as Low Dose Budesonide
- Expertise Asthma COPD Program with Digital SupportRecruitingPhase 3Franciscus GasthuisNCT05831566Written as Budesonide/Formoterol fumarate dihydrate
- Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEctionNot yet recruitingNot applicableHuashan HospitalNCT06597682Written as Budesonide/Formoterol
- Budesonide As a Treatment for Functional DyspepsiaRecruitingPhase 4Universitaire Ziekenhuizen KU LeuvenNCT06841406Written as budesonide
See all 307 studies that test Budesonide →
Given beside what is tested · 32 — Budesonide is usual care or a partner of the new treatment
- Fasenra: An Asthma StudyEnrolling by invitationPhase 4Endeavor HealthNCT07654842Written as Budesonide-albuterol
- Nasal Obstruction With Oxymetazoline and CorticosteroidsRecruitingPhase 2Washington University School of MedicineNCT06830109Written as Budesonide nasal spray
- Combination of Diet and Oral Budesonide for Ulcerative ColitisRecruitingNot applicableWolfson Medical CenterNCT05791487Written as Oral Budesonide
- Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDSRecruitingPhase 1Ain Shams UniversityNCT06367881Written as Budesonide
- Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.Active, not recruitingPhase 3AstraZenecaNCT06473779Written as Budesonide/formoterol
- Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic PatientsCompletedPhase 2Zambon SpANCT02227394Written as Symbicort® Turbohaler®
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive, not recruitingPhase 2SanofiNCT06676319Written as Budesonide/Formoterol
- Inhaled vs Intranasal Corticosteroids for Chronic Cough in Upper Airway Cough SyndromeCompletedNot applicableSilesian University of MedicineNCT07777796Written as Budesonide (400μg/d)
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseCompletedPhase 2National Cancer Institute (NCI)NCT04294641Written as Budesonide
- Dupilumab in Chinese Adult Participants With CRSwNPCompletedPhase 3SanofiNCT05878093Written as Budesonide
- Acupuncture Therapy for COVID-Related Olfactory LossCompletedNot applicableMayo ClinicNCT04952389Written as Budesonide
- An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and LoperamideCompletedPhase 2Puma Biotechnology, Inc.NCT02400476Written as Budesonide
- Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCompletedPhase 2SanofiNCT02573233Written as budesonide and formoterol
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478696Written as budesonide/formoterol
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478683Written as budesonide/formoterol
- Comparison of Montelukast and Azelastine in Treatment of Moderate to Severe Allergic RhinitisStatus unknownNot applicableShiraz University of Medical SciencesNCT04561687Written as Budesonide
- Comparing Budesonide Via MAD or INSI Prospective Cohort StudyStatus unknownEarly Phase 1St. Paul's Hospital, CanadaNCT04267042Written as Budesonide
- Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort StudyCompletedEarly Phase 1St. Paul's Hospital, CanadaNCT04097613Written as Budesonide
- Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedPhase 4AstraZenecaNCT01415518Written as Drug: Budesonide/formoterol (Symbicort Turbuhaler
- Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated AsthmaTerminatedPhase 4Novartis PharmaceuticalsNCT01912872Written as Budesonide
Showing 20 of 32.
As the comparator · 26 — what is tested is compared with Budesonide
- A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaRecruitingPhase 3Novartis PharmaceuticalsNCT05562466Written as Budesonide
- Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing TonsillectomyNot yet recruitingPhase 4Assiut UniversityNCT06158893Written as Budesonide
- Efficacy and Safety of CP006 Inhalation Powder in Participants With AsthmaCompletedPhase 2Shanghai Xin Huanghe Pharmaceutical Co., Ltd.NCT07807007Written as Budesonide and Formoterol Fumarate
- Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)CompletedPhase 3Chiesi Farmaceutici S.p.A.NCT03197818Written as 160 µg budesonide + 4.5 µg formoterol fumarate
- A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)CompletedPhase 3Organon and CoNCT00442117Written as Budesonide DPI
- Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®CompletedPhase 3Teva Branded Pharmaceutical Products R&D, Inc.NCT01803555Written as SYMBICORT® TURBOHALER®
- Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)CompletedPhase 2Sanotize Research and Development corp.NCT04163978Written as Budesonide
- Ivermectin Nasal Drops in Post COVID-19 ParosmiaStatus unknownPhase 2Menoufia UniversityNCT05269030Written as Budesonide Nasal
- Vitamin D Nasal Drops in Post COVID-19 ParosmiaStatus unknownPhase 2Menoufia UniversityNCT05269017Written as Budesonide nasal spray
- Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)CompletedPhase 3Chiesi Farmaceutici S.p.A.NCT00413387Written as budesonide plus formoterol combination
- (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative ColitisCompletedPhase 3Bausch Health Americas, Inc.NCT00679380Written as Entocort EC® 3 mg
- Antibiotics and Hydroxychloroquine in Crohn'sCompletedPhase 2Royal Liverpool University HospitalNCT01783106Written as Budesonide
- A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPDCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT02986321Written as Budesonide
- A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent AsthmaCompletedPhase 3GlaxoSmithKlineNCT02446418Written as Budesonide
- Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent AsthmaCompletedPhase 3GlaxoSmithKlineNCT01687283Written as budesonide suspension
- Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With PolyposisCompletedPhase 3University of MichiganNCT01197612Written as pulmicort
- Small Airways Evaluation and TreatmentStatus unknownPhase 4Zhujiang HospitalNCT02526758Written as budesonide
- The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled AllergenCompletedPhase 2AstraZenecaNCT01225549Written as Budesonide 200 microgram
- Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of FormoterolCompletedPhase 2AstraZenecaNCT01555099Written as Budesonide
- Comparison of Efficacy of Nebulizing Budesonide and Intravenous Dexamethasone Before Extubation on Prevention of Post-extubation Complications in Intensive Care Unit PatientsStatus unknownNot applicableSaeed AbbasiNCT01854515Written as Budesonide
Showing 20 of 26.
What changed recently
From the registry's own updates since Oct 15, 2026.
Newly registered1
Codes
What other systems call Budesonide · ClinicalTrials.gg INT008728
- MeSH (NLM) D019819BudesonideConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) Q3OKS62Q6XBUDESONIDEConfirmed FDA, Wikidata
- RxNorm 19831Confirmed FDA, Wikidata
- Wikidata Q422212budesonideConfirmed FDA, Wikidata
- NCI Thesaurus C1027BudesonideOne source FDA
- DrugBank DB01222One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019819 | Budesonide | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | Q3OKS62Q6X | BUDESONIDE | Confirmed FDA, Wikidata |
| RxNorm | 19831 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422212 | budesonide | Confirmed FDA, Wikidata |
| NCI Thesaurus | C1027 | Budesonide | One source FDA |
| DrugBank | DB01222 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.